693 related articles for article (PubMed ID: 27046523)
1. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
[TBL] [Abstract][Full Text] [Related]
2. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
Thomas RH; Luthin DR
Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
[TBL] [Abstract][Full Text] [Related]
3. Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation.
Chang L; Chey WD; Drossman D; Losch-Beridon T; Wang M; Lichtlen P; Mareya S
Aliment Pharmacol Ther; 2016 Nov; 44(10):1114-1122. PubMed ID: 27669680
[TBL] [Abstract][Full Text] [Related]
4. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.
Black CJ; Burr NE; Quigley EMM; Moayyedi P; Houghton LA; Ford AC
Gastroenterology; 2018 Dec; 155(6):1753-1763. PubMed ID: 30144426
[TBL] [Abstract][Full Text] [Related]
6. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
7. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
Videlock EJ; Cheng V; Cremonini F
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: lubiprostone efficacy on the treatment of patients with constipation.
Passos MDCF; Takemoto MLS; Corradino GC; Guedes LS
Arq Gastroenterol; 2020; 57(4):498-506. PubMed ID: 33331483
[TBL] [Abstract][Full Text] [Related]
9. Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.
Owen RT
Drugs Today (Barc); 2008 Sep; 44(9):645-52. PubMed ID: 19137119
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.
Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R
Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656
[TBL] [Abstract][Full Text] [Related]
11. Lubiprostone: chronic constipation and irritable bowel syndrome with constipation.
Lacy BE; Chey WD
Expert Opin Pharmacother; 2009 Jan; 10(1):143-52. PubMed ID: 19236188
[TBL] [Abstract][Full Text] [Related]
12. Lubiprostone for chronic idiopathic constipation and irritable bowel syndrome with constipation.
Saad R; Chey WD
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):497-508. PubMed ID: 19072397
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
Brenner DM; Fogel R; Dorn SD; Krause R; Eng P; Kirshoff R; Nguyen A; Crozier RA; Magnus L; Griffin PH
Am J Gastroenterol; 2018 May; 113(5):735-745. PubMed ID: 29545635
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
Shah E; Kim S; Chong K; Lembo A; Pimentel M
Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.
Drossman DA; Chey WD; Johanson JF; Fass R; Scott C; Panas R; Ueno R
Aliment Pharmacol Ther; 2009 Feb; 29(3):329-41. PubMed ID: 19006537
[TBL] [Abstract][Full Text] [Related]
16. Tegaserod for the treatment of irritable bowel syndrome.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of lubiprostone in patients with chronic constipation.
Barish CF; Drossman D; Johanson JF; Ueno R
Dig Dis Sci; 2010 Apr; 55(4):1090-7. PubMed ID: 20012484
[TBL] [Abstract][Full Text] [Related]
19. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
[TBL] [Abstract][Full Text] [Related]
20. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.
Lacy BE; Schey R; Shiff SJ; Lavins BJ; Fox SM; Jia XD; Blakesley RE; Hao X; Cronin JA; Currie MG; Kurtz CB; Johnston JM; Lembo AJ
PLoS One; 2015; 10(7):e0134349. PubMed ID: 26222318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
